AbCellera Biologics Inc.ABCLNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+13.0%
5Y CAGR+42.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+13.0%/yr
vs +114.4%/yr prior
5Y CAGR
+42.4%/yr
Recent deceleration
Acceleration
-101.4pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
5.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $292.23M | -14.9% |
| 2024 | $343.60M | +24.8% |
| 2023 | $275.23M | +35.9% |
| 2022 | $202.48M | +61.6% |
| 2021 | $125.27M | +150.6% |
| 2020 | $49.98M | +217.8% |
| 2019 | $15.73M | +64.1% |
| 2018 | $9.58M | - |